HUP0401443A3 - Glycine-substituted thieno[2,3-d]pyrimidines with lh and fsh agonistic activity, use of the compounds and pharmaceutical compositions containing same - Google Patents
Glycine-substituted thieno[2,3-d]pyrimidines with lh and fsh agonistic activity, use of the compounds and pharmaceutical compositions containing sameInfo
- Publication number
- HUP0401443A3 HUP0401443A3 HU0401443A HUP0401443A HUP0401443A3 HU P0401443 A3 HUP0401443 A3 HU P0401443A3 HU 0401443 A HU0401443 A HU 0401443A HU P0401443 A HUP0401443 A HU P0401443A HU P0401443 A3 HUP0401443 A3 HU P0401443A3
- Authority
- HU
- Hungary
- Prior art keywords
- pyrimidines
- glycine
- compounds
- pharmaceutical compositions
- compositions containing
- Prior art date
Links
- -1 Glycine-substituted thieno[2,3-d]pyrimidines Chemical class 0.000 title 1
- 230000001270 agonistic effect Effects 0.000 title 1
- 150000001875 compounds Chemical class 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
- A61P5/08—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH for decreasing, blocking or antagonising the activity of the anterior pituitary hormones
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Endocrinology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Reproductive Health (AREA)
- Diabetes (AREA)
- Gynecology & Obstetrics (AREA)
- Pregnancy & Childbirth (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP01203328 | 2001-09-04 | ||
| PCT/EP2002/009648 WO2003020727A1 (en) | 2001-09-04 | 2002-08-29 | GLYCINE-SUBSTITUTED THIENO [2,3-d]PYRIMIDINES WITH COMBINED LH AND FSH AGONISTIC ACTIVITY |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| HUP0401443A2 HUP0401443A2 (hu) | 2004-11-29 |
| HUP0401443A3 true HUP0401443A3 (en) | 2008-05-28 |
Family
ID=8180877
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HU0401443A HUP0401443A3 (en) | 2001-09-04 | 2002-08-29 | Glycine-substituted thieno[2,3-d]pyrimidines with lh and fsh agonistic activity, use of the compounds and pharmaceutical compositions containing same |
Country Status (27)
| Country | Link |
|---|---|
| US (1) | US7375109B2 (hu) |
| EP (1) | EP1427734B1 (hu) |
| JP (1) | JP4263094B2 (hu) |
| KR (1) | KR100891630B1 (hu) |
| CN (1) | CN1261437C (hu) |
| AR (1) | AR036408A1 (hu) |
| AT (1) | ATE309251T1 (hu) |
| AU (1) | AU2002333750B2 (hu) |
| BR (1) | BR0212173A (hu) |
| CA (1) | CA2457212C (hu) |
| CY (1) | CY1106052T1 (hu) |
| DE (1) | DE60207280T2 (hu) |
| DK (1) | DK1427734T3 (hu) |
| EC (1) | ECSP044990A (hu) |
| ES (1) | ES2252540T3 (hu) |
| HR (1) | HRP20040194A2 (hu) |
| HU (1) | HUP0401443A3 (hu) |
| IL (2) | IL160194A0 (hu) |
| IS (1) | IS2419B (hu) |
| MX (1) | MXPA04002046A (hu) |
| NO (1) | NO328792B1 (hu) |
| NZ (1) | NZ531375A (hu) |
| PE (1) | PE20030467A1 (hu) |
| PL (1) | PL368388A1 (hu) |
| RU (1) | RU2294331C2 (hu) |
| WO (1) | WO2003020727A1 (hu) |
| ZA (1) | ZA200401459B (hu) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6890923B2 (en) * | 2002-12-16 | 2005-05-10 | Astrazeneca Ab | Compounds |
| KR100666484B1 (ko) * | 2005-02-04 | 2007-01-09 | 삼성전자주식회사 | 반도체 메모리 장치의 입출력 회로 및 입출력 방법 |
| JP5718233B2 (ja) | 2008-10-20 | 2015-05-13 | ザ ガバメント オブ ザ ユナイテッド ステイツ オブ アメリカ アズ リプレゼンテッド バイ ザ セクレタリー オブ ザ デパートメント オブ ヘルス アンド ヒューマン サービシーズ | 甲状腺刺激ホルモン受容体（ｔｓｈｒ）の低分子量アゴニスト |
| CN101762915B (zh) * | 2008-12-24 | 2013-04-17 | 北京京东方光电科技有限公司 | Tft-lcd阵列基板及其驱动方法 |
| EP2563777A4 (en) | 2010-04-08 | 2013-09-04 | Us Health | INVERSE AGONISTS AND NEUTRAL AGONISTS FOR THE TSH RECEPTOR |
| SI3415517T1 (sl) * | 2012-09-28 | 2022-06-30 | Takeda Pharmaceutical Company Limited | Kristalna oblika 1-(4-1-(2,6-difluorobenzil)-5-dimetilaminometil-3-(6- metoksipiridazin-3-il)-2,4-diokso-1,2,3,4-tetrahidrotieno(2,3-D)- pirimidin-6il)fenil)-3-metoksiurea |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE86484T1 (de) | 1987-08-08 | 1993-03-15 | Akzo Nv | Kontrazeptives implantat. |
| TW564247B (en) * | 1999-04-08 | 2003-12-01 | Akzo Nobel Nv | Bicyclic heteraromatic compound |
-
2002
- 2002-08-29 DK DK02797646T patent/DK1427734T3/da active
- 2002-08-29 WO PCT/EP2002/009648 patent/WO2003020727A1/en active IP Right Grant
- 2002-08-29 HU HU0401443A patent/HUP0401443A3/hu unknown
- 2002-08-29 AU AU2002333750A patent/AU2002333750B2/en not_active Ceased
- 2002-08-29 AT AT02797646T patent/ATE309251T1/de not_active IP Right Cessation
- 2002-08-29 IL IL16019402A patent/IL160194A0/xx unknown
- 2002-08-29 ES ES02797646T patent/ES2252540T3/es not_active Expired - Lifetime
- 2002-08-29 CN CNB02817240XA patent/CN1261437C/zh not_active Expired - Fee Related
- 2002-08-29 CA CA2457212A patent/CA2457212C/en not_active Expired - Fee Related
- 2002-08-29 NZ NZ531375A patent/NZ531375A/en not_active IP Right Cessation
- 2002-08-29 RU RU2004110036/04A patent/RU2294331C2/ru not_active IP Right Cessation
- 2002-08-29 DE DE60207280T patent/DE60207280T2/de not_active Expired - Lifetime
- 2002-08-29 BR BR0212173-5A patent/BR0212173A/pt not_active IP Right Cessation
- 2002-08-29 EP EP02797646A patent/EP1427734B1/en not_active Expired - Lifetime
- 2002-08-29 US US10/488,483 patent/US7375109B2/en not_active Expired - Lifetime
- 2002-08-29 KR KR1020047003096A patent/KR100891630B1/ko not_active IP Right Cessation
- 2002-08-29 PL PL02368388A patent/PL368388A1/xx not_active Application Discontinuation
- 2002-08-29 JP JP2003524997A patent/JP4263094B2/ja not_active Expired - Fee Related
- 2002-08-29 MX MXPA04002046A patent/MXPA04002046A/es active IP Right Grant
- 2002-09-02 AR ARP020103310A patent/AR036408A1/es unknown
- 2002-09-03 PE PE2002000839A patent/PE20030467A1/es not_active Application Discontinuation
-
2004
- 2004-02-03 IL IL160194A patent/IL160194A/en not_active IP Right Cessation
- 2004-02-13 IS IS7152A patent/IS2419B/is unknown
- 2004-02-23 ZA ZA200401459A patent/ZA200401459B/en unknown
- 2004-02-26 EC EC2004004990A patent/ECSP044990A/es unknown
- 2004-02-26 HR HR20040194A patent/HRP20040194A2/hr not_active Application Discontinuation
- 2004-03-03 NO NO20040922A patent/NO328792B1/no not_active IP Right Cessation
-
2005
- 2005-12-22 CY CY20051101587T patent/CY1106052T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HUP0200653A2 (en) | Bicyclic heteroaromatic compounds useful as lh agonists, pharmaceutical compositions containing them and their use | |
| HUP0301114A3 (en) | Pyrrolo[2,3-d]pyrimidine compounds as immunosuppressive agents and pharmaceutical compositions containing them | |
| HK1036800A1 (en) | Pyrrolo(2,3-d)pyrimidine compounds, its composition and use thereof | |
| HUP0402336A3 (en) | Thieno[2,3-d]pyrimidine-2,4-dione derivatives, process for their preparation, their use in the modulation of autoimmune disease and pharmaceutical compositions containing them | |
| HK1043591B (zh) | 取代的2-芳基-3-(雜芳基)-咪唑並[1，2-a]嘧啶類化合物以及相關的藥物組合物和方法 | |
| HK1036801A1 (en) | Pyrrolo(2,3-d)pyrimidine compounds, composition and use there of | |
| HUP0401301A3 (en) | Pyrrolo pyrimidines, process for their preparation, their use and pharmaceutical compositions containing them | |
| HUP0401083A3 (en) | 4-amino-6-phenyl-pyrrolo [2,3-d] pyrimidine derivatives, pharmaceutical compositions containing them and process for the preparation of the compounds | |
| PT1382339E (pt) | Composições que contêm derivados de pirrolo[2,3-d]- pirimidina | |
| HUP0200803A3 (en) | Substituted bicyclic heteroaryl compounds as integrin antagonists, pharmaceutical compositions containing them and the intermediates | |
| HUP0400692A3 (en) | Substituted 7h-pyrrolo[2,3-d]pyrimidine derivatives, their use and pharmaceutical compositions containing them | |
| HUP0204413A3 (en) | Quinazoline compounds, their preparation, their use and pharmaceutical compositions containing them | |
| IL156536A0 (en) | Pyrazolo [3,4-d] pyrimidin-4-one derivatives and pharmaceutical compositions containing the same | |
| HUP0401444A3 (en) | Thieno[2,3-d]pyrimidines with combined lh and fsh agonistic activity, use of the compounds and pharmaceutical compositions containing the same | |
| AU2002352476A1 (en) | Urea derivatives and their use as vanilloid receptor antagonists | |
| HUP0201730A2 (en) | Thienopyrimidines as phosphodiesterase inhibitors, their use, pharmaceutical compositions containing them and process for the preparation thereof | |
| HUP0301587A3 (en) | 5-aminoalkyl-pyrazolo[4,3-d]pyrimidines with a phosphodiesterase v-inhibiting effect, pharmaceutical compositions containing them and processes for their preparations | |
| HUP0303005A3 (en) | Pharmaceutical compositions comprising pyrazolo[4,3-d]pyrimidines or thienopyrimidines and endothelin receptor antagonists | |
| HUP0401443A3 (en) | Glycine-substituted thieno[2,3-d]pyrimidines with lh and fsh agonistic activity, use of the compounds and pharmaceutical compositions containing same | |
| HUP0302648A3 (en) | Bicyclic heteroaromatic compounds, pharmaceutical compositions containing them and their use | |
| HUP0104350A3 (en) | Synergetic fungicidal composition comprising thieno[2,3-d]pyrimidin-4-one and its use | |
| PL363077A1 (en) | Use of pyrazolo[4,3-d]pyrimidines | |
| PL362408A1 (en) | Pharmaceutical formulation containing pyrazolo[4,3-d]pyrimidine and nitrates or thienopyrimidines and nitrates | |
| HUP0303399A3 (en) | Compounds useful for the preparation of pharmaceutical compositions with phosphodiesterase iv inhibitory activity | |
| PL366437A1 (en) | Use of substituted imidazo 1,2-a]-pyridine-3-yl-amide and imidazo 1,2-a]-pyridine-3-yl-amine compounds as medicaments |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| GB9A | Succession in title |
Owner name: N.V. ORGANON, NL Free format text: FORMER OWNER(S): AKZO NOBEL N.V., NL |
|
| FA9A | Lapse of provisional patent protection due to relinquishment or protection considered relinquished |